| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tracon Pharmaceuticals, Inc. | Director | Director Stock Option (Right to Buy) | 18K | Apr 19, 2023 | Direct | ||
| Oncternal Therapeutics, Inc. | Director | Stock Options | 2.2K | Jun 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | Director |
| ONCT | Oncternal Therapeutics, Inc. | Jun 28, 2023 | 1 | $0 | 4 | Jun 30, 2023 | Director |
| TCON | Tracon Pharmaceuticals, Inc. | Apr 19, 2023 | 1 | $0 | 4 | Apr 21, 2023 | Director |
| TCON | Tracon Pharmaceuticals, Inc. | Dec 21, 2022 | 1 | -$151 | 4 | Jan 19, 2023 | Director |
| ONCT | Oncternal Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| TCON | Tracon Pharmaceuticals, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| TCON | Tracon Pharmaceuticals, Inc. | Jul 26, 2021 | 1 | $25K | 4 | Jul 27, 2021 | Director |
| TCON | Tracon Pharmaceuticals, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 24, 2021 | Director |
| ONCT | Oncternal Therapeutics, Inc. | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |